Vo, T. (2018). Impact of Biomarker-based Design Strategies on the Risk of False-Positive Findings in Targeted Therapy Evaluation. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationVo, T.-T. Impact of Biomarker-based Design Strategies on the Risk of False-Positive Findings in Targeted Therapy Evaluation. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationVo, T.-T. Impact of Biomarker-based Design Strategies on the Risk of False-Positive Findings in Targeted Therapy Evaluation. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.